
Aquestive Therapeutics, Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Aquestive Therapeutics is a pharmaceutical company that develops and manufactures drug products using proprietary oral film and other delivery technologies, including treatments for neurological and other conditions. It also manufactures products for third-party pharmaceutical partners under licensing and supply agreements.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Barber DanielPresident and CEO | Sell | $106K | 25,000at $4.22 | Oct 15, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable AQST activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.